Goldenwell Biotech Statistics
Total Valuation
GWLL has a market cap or net worth of 267.30 million. The enterprise value is 267.50 million.
| Market Cap | 267.30M |
| Enterprise Value | 267.50M |
Important Dates
The next estimated earnings date is Wednesday, November 26, 2025.
| Earnings Date | Nov 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
GWLL has 99.00 million shares outstanding.
| Current Share Class | 99.00M |
| Shares Outstanding | 99.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -2.59% |
| Owned by Insiders (%) | 63.64% |
| Owned by Institutions (%) | n/a |
| Float | 36.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 7,158.16 |
| PB Ratio | -3,078.15 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2,965.70 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.90
| Current Ratio | 3.90 |
| Quick Ratio | 1.19 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.74 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -22.64% |
| Return on Invested Capital (ROIC) | -26.48% |
| Return on Capital Employed (ROCE) | -43.76% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | 2.09 |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 89.08 |
| Average Volume (20 Days) | 5,193 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GWLL had revenue of 37,342 and -90,197 in losses. Loss per share was -0.00.
| Revenue | 37,342 |
| Gross Profit | 37,415 |
| Operating Income | -81,797 |
| Pretax Income | -90,197 |
| Net Income | -90,197 |
| EBITDA | n/a |
| EBIT | -81,797 |
| Loss Per Share | -0.00 |
Balance Sheet
The company has 76,507 in cash and 273,773 in debt, giving a net cash position of -197,266 or -0.00 per share.
| Cash & Cash Equivalents | 76,507 |
| Total Debt | 273,773 |
| Net Cash | -197,266 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -86,838 |
| Book Value Per Share | -0.00 |
| Working Capital | 186,935 |
Cash Flow
| Operating Cash Flow | -19,212 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 100.20%, with operating and profit margins of -219.05% and -241.54%.
| Gross Margin | 100.20% |
| Operating Margin | -219.05% |
| Pretax Margin | -241.54% |
| Profit Margin | -241.54% |
| EBITDA Margin | n/a |
| EBIT Margin | -219.05% |
| FCF Margin | n/a |
Dividends & Yields
GWLL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -0.03% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
GWLL has an Altman Z-Score of 27.31 and a Piotroski F-Score of 3.
| Altman Z-Score | 27.31 |
| Piotroski F-Score | 3 |